Overview
- Product nameAnti-C9 antibodySee all C9 primary antibodies ...
- DescriptionRabbit polyclonal to C9
- Tested applicationsWB, IHC-P, ICC/IF more details
- Species reactivityReacts with: Human
- Immunogen
Recombinant Human C9 protein.
- Positive controlHuman Small Intestine, Vessels Human Placenta methanol-fixed HepG2 Raji cell lysate
Properties
- FormLiquid
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
- Storage bufferpH: 7.00
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 10% Glycerol, 1.21% Tris glycine -
Concentration information loading... - PurityImmunogen affinity purified
- Clonality Polyclonal
- IsotypeIgG
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab118902 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | WB: 1/500 - 1/3000. Predicted molecular weight: 62 kDa. |
| IHC-P | IHC-P: Use a concentration of 10 µg/ml. |
| ICC/IF | ICC/IF: 1/100 - 1/200. |
Target
- FunctionConstituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C9 is the pore-forming subunit of the MAC.
- Tissue specificityPlasma.
- Involvement in diseaseDefects in C9 are a cause of complement component 9 deficiency (C9D) [MIM:613825]. A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis.
- Sequence similaritiesBelongs to the complement C6/C7/C8/C9 family.
Contains 1 EGF-like domain.
Contains 1 LDL-receptor class A domain.
Contains 1 MACPF domain.
Contains 1 TSP type-1 domain. - Post-translational
modificationsThrombin cleaves factor C9 to produce C9a and C9b.
Phosphorylation sites are present in the extracelllular medium. - Cellular localizationSecreted. Cell membrane. Secreted as soluble monomer. Oligomerizes at target membranes, forming a pre-pore. A conformation change then leads to the formation of a 100 Angstrom diameter pore.
-
Database links
- Entrez Gene: 735 Human
- Omim: 120940 Human
- SwissProt: P02748 Human
- Unigene: 654443 Human
Target information above from: UniProt accession
P02748
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- C9 antibodyC9 deficiency antibodyC9 deficiency with dermatomyositis antibody
- CO9_HUMAN antibodyComplement component 9 antibodyComplement component 9 deficiency antibodyComplement component C9 antibodyComplement component C9b antibody
see all
Anti-C9 antibody images
-
Immunohistochemistry analysis (Formalin-Fixed, Paraffin-Embedded) of Human Small Intestine, Vessels stained with ab118902 at 10 µg/ml
-
Immunohistochemistry analysis (Formalin-Fixed, Paraffin-Embedded) of Human Placenta stained with ab118902 at 10 µg/ml
-
Immunofluorescence analysis of methanol-fixed HepG2, using ab118902 at 1:200 dilution.
-
Anti-C9 antibody (ab118902) at 1/500 dilution + Raji cell lysate at 30 µg
Predicted band size : 62 kDa
References for Anti-C9 antibody (ab118902)
ab118902 has not yet been referenced specifically in any publications.



